Data as of Jul 25
| -0.08 / -0.70%|
The 2 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 15.51, with a high estimate of 17.00 and a low estimate of 14.02. The median estimate represents a +37.26% increase from the last price of 11.30.
The current consensus among 1 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.